Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125849642 | 12584964 | 2 | F | 20160711 | 20160825 | 20160722 | 20160902 | EXP | US-JAZZ-2016-US-013393 | JAZZ | 25.02 | YR | F | Y | 81.18000 | KG | 20160902 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125849642 | 12584964 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 125849642 | 12584964 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
| 125849642 | 12584964 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.75 G, BID | 21196 | 3.75 | G | ORAL SOLUTION | |||||||
| 125849642 | 12584964 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | 3.75 G, BID | 21196 | 3.75 | G | ORAL SOLUTION | ||||||||
| 125849642 | 12584964 | 5 | SS | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | UNK | 0 | TABLET | ||||||||||
| 125849642 | 12584964 | 6 | C | ADDERALL XR | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 10 MG | U | 0 | CAPSULE | |||||||||
| 125849642 | 12584964 | 7 | C | ADDERALL XR | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 10 MG | U | 0 | CAPSULE | |||||||||
| 125849642 | 12584964 | 8 | C | Albuterol sulfate hfa | 2 | U | 0 | INHALER | |||||||||||
| 125849642 | 12584964 | 9 | C | ARMOUR THYROID | THYROID, PORCINE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125849642 | 12584964 | 10 | C | EPIPEN | EPINEPHRINE | 1 | U | 0 | |||||||||||
| 125849642 | 12584964 | 11 | C | ORTHO TRI CYCLEN LO | ETHINYL ESTRADIOLNORGESTIMATE | 1 | U | 0 | TABLET | ||||||||||
| 125849642 | 12584964 | 12 | C | PHENTERMINE. | PHENTERMINE | 1 | UNK | U | 0 | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125849642 | 12584964 | 1 | Narcolepsy |
| 125849642 | 12584964 | 5 | Procedural pain |
| 125849642 | 12584964 | 6 | Product used for unknown indication |
| 125849642 | 12584964 | 8 | Product used for unknown indication |
| 125849642 | 12584964 | 9 | Product used for unknown indication |
| 125849642 | 12584964 | 10 | Product used for unknown indication |
| 125849642 | 12584964 | 11 | Product used for unknown indication |
| 125849642 | 12584964 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125849642 | 12584964 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125849642 | 12584964 | Dizziness | |
| 125849642 | 12584964 | Ligament rupture | |
| 125849642 | 12584964 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125849642 | 12584964 | 1 | 201605 | 201605 | 0 | |
| 125849642 | 12584964 | 2 | 201605 | 201606 | 0 | |
| 125849642 | 12584964 | 3 | 201606 | 20160710 | 0 | |
| 125849642 | 12584964 | 4 | 20160713 | 20160713 | 0 | |
| 125849642 | 12584964 | 5 | 201607 | 0 | ||
| 125849642 | 12584964 | 6 | 201605 | 0 | ||
| 125849642 | 12584964 | 7 | 201606 | 0 | ||
| 125849642 | 12584964 | 9 | 201605 | 0 | ||
| 125849642 | 12584964 | 12 | 201606 | 0 |